New research reveals that individuals who discontinue new weight-loss injections like semaglutide or tirzepatide tend to recover reduced body mass much more quickly than those who halt conventional lifestyle programs.
Published data in a prominent medical journal points out that while overweight people can lose substantial amounts of their total mass while on the medication, the mass comes back at an estimated rate of nearly a kilo each month upon discontinuation.
"People purchasing such medications should be aware of the risk of rapid weight regain when the treatment is stopped," cautioned lead investigator Dr. Susan Jebb.
Such speed of regain implies a return to original weight within about a year and a half.
Analyzing Therapies
The research, which examined 37 of studies involving thousands of patients, contrasted the effects of the injectable medications with other pills.
Scientists note that individuals who shed pounds through dieting generally see a more gradual creep back—around 100 grams monthly—post-intervention.
Explaining the Rapid Regain
Doctors believe the way of the jabs explains the heightened rebound.
These medications mimic a natural hormone called glucagon-like peptide-1, which helps regulate feelings of fullness.
"Artificially providing the hormone concentrations far above than the body's typical production may cause the system to produce less of its endogenous GLP-1, and could diminish sensitivity to its effects," explained Dr. Adam Collins, a dietetics specialist.
"Withdrawal of this hormone supplement results in hunger is uncontrolled, making excessive eating far more likely."
An Ongoing Disease?
The NHS recommend the injections for individuals with obesity-related medical conditions, accompanied by prescribed diet and exercise modifications.
Many experts argue that, considering the likelihood of relapse, the therapy might need to be life-long.
This opinion is reinforced by pharmaceutical companies, who state that the results "highlight the persistent nature of obesity," similar to managing diseases like diabetes.
Patient Experiences
Individuals who have discontinued the jabs report a sudden resurgence of appetite.
"It was like a trigger activating and you're instantly starving," said one woman.
This challenge is compounded if users have not developed lasting dietary or behavioural modifications during therapy.
Widespread Use
Survey data indicate that a significant number of people in the UK have used these injections in the past year, with desire remaining high.
- Adoption is higher among females compared to males.
- The 40s and 50s demographic shows the highest usage rates.
- Many access the medications through private prescriptions rather than public health services.
In conclusion, researchers stress that while these medications are potent agents for shedding pounds, they are not a standalone cure and long-term success relies on integrated lifestyle support.